Thu, Aug 28, 2014, 4:01 AM EDT - U.S. Markets open in 5 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

Regenerx Biopharmaceuticals Inc. Message Board

  • snogreen snogreen Jul 23, 2013 7:52 AM Flag

    Combine Memetogen drug & TB 4.

    Know what makes sense? What about making a two for one drug, combining Mimetogen's and TB 4 together. Both are totally safe. Both are naturally ocuring. Both just turbo charge what is already there. Mimetogen fialed it's phase 2 primary for OVERALL cornea. RGRX failed in it's Phase 2 primary - ONLY the INFERIOR region of cornea. But Mimetgen got good results in the INFERIOR region of cornea, but not overall cornea. Conversely, RGRX didn't do well in INFERIOR cornea, but got over the top P values in the CENTRAL and SUPERIOR regions of te cornea.....places where Mimetogen drug flopped.. Multiple combination drugs are used all the time in many doseasse areas (look at HCV). And often with bad side effects. Neither Mimetigen or RGRX drug has any safety or side effect issues..and where each drug worked or flopped, the others didn't. TB 4 and Mimetogen drugs combined compliment response. - just going off what I see on the phase 2 results - would be a category killer drug.in a $1 billion market. But don't hold your breath. Finkelstein is in charge here, Someone should contact George Ousler at ORA Inc....he did BOTH Mimetohen and TB 4 trials...and he worked with Bausch & Lomb, I'm sure.. Someone should clue in Finkelstein too.

 
RGRX
0.121-0.009(-6.85%)Aug 27 3:40 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
TubeMogul, Inc.
NasdaqGSWed, Aug 27, 2014 4:00 PM EDT
Burger King Worldwide, Inc.
NYSEWed, Aug 27, 2014 4:00 PM EDT